Flag Ship Acquisition (NASDAQ:ETHZ) Shares Up 2.1% – Still a Buy?

Flag Ship Acquisition Corp. (NASDAQ:ETHZ) shares shot up 2.1% on Thursday . The company traded as high as $4.96 and last traded at $4.87. 443,778 shares traded hands during trading, a decline of 93% from the average session volume of 6,436,919 shares. The stock had previously closed at $4.77.

Flag Ship Acquisition Price Performance

The stock has a 50 day moving average price of $3.79 and a two-hundred day moving average price of $5.01. The company has a debt-to-equity ratio of 1.11, a quick ratio of 10.07 and a current ratio of 10.07. The company has a market capitalization of $92.59 million, a PE ratio of -0.03 and a beta of 1.17.

Institutional Investors Weigh In On Flag Ship Acquisition

An institutional investor recently bought a new position in Flag Ship Acquisition stock. DRW Securities LLC purchased a new position in shares of Flag Ship Acquisition Corp. (NASDAQ:ETHZ) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 270,733 shares of the company’s stock, valued at approximately $1,327,000. DRW Securities LLC owned approximately 1.42% of Flag Ship Acquisition at the end of the most recent reporting period. 4.07% of the stock is currently owned by institutional investors.

Flag Ship Acquisition Company Profile

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor.